WallStreetZenWallStreetZen

NASDAQ: MYNZ
Mainz Biomed Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MYNZ stock forecasts and price targets.

Forecast return on equity

Is MYNZ forecast to generate an efficient return?

Company
N/A
Industry
14.1%
Market
209.24%

Forecast return on assets

Is MYNZ forecast to generate an efficient return on assets?

Company
N/A
Industry
16.99%

MYNZ earnings per share forecast

What is MYNZ's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.38
Avg 2 year Forecast
-$1.50

MYNZ revenue forecast

What is MYNZ's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$936.4k+41.89%
Avg 2 year Forecast
$2.5M+285.19%
Avg 3 year Forecast
$30.8M+4,561.82%
MYNZ's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MYNZ revenue growth forecast

How is MYNZ forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
241.7%
Industry
7.86%
Market
22.91%
MYNZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MYNZ's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MYNZ vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MYNZ$1.18N/AN/A
NDRA$4.62$30.00+549.35%Buy
BIAF$1.29N/AN/A
ISPC$0.32N/AN/A
XWEL$0.46N/AN/A
View Top Diagnostic & Research Stocks

Mainz Biomed Nv Stock Forecast FAQ

What is MYNZ's earnings growth forecast for 2026-2027?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 19.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.52%.

Mainz Biomed Nv's earnings in 2026 is -$18,971,112.On average, 3 Wall Street analysts forecast MYNZ's earnings for 2026 to be -$5,634,482, with the lowest MYNZ earnings forecast at -$5,413,522, and the highest MYNZ earnings forecast at -$5,800,202.

In 2027, MYNZ is forecast to generate -$6,135,324 in earnings, with the lowest earnings forecast at -$5,894,723 and the highest earnings forecast at -$6,315,775.

If you're new to stock investing, here's how to buy Mainz Biomed Nv stock.

What is MYNZ's revenue growth forecast for 2026-2028?

(NASDAQ: MYNZ) Mainz Biomed Nv's forecast annual revenue growth rate of 241.7% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.86%, and it is also forecast to beat the US market's average forecast revenue growth rate of 22.91%.

Mainz Biomed Nv's revenue in 2026 is $659,935.On average, 3 Wall Street analysts forecast MYNZ's revenue for 2026 to be $3,831,447, with the lowest MYNZ revenue forecast at $3,681,195, and the highest MYNZ revenue forecast at $3,944,137. On average, 3 Wall Street analysts forecast MYNZ's revenue for 2027 to be $10,401,490, with the lowest MYNZ revenue forecast at $9,992,305, and the highest MYNZ revenue forecast at $10,708,379.

In 2028, MYNZ is forecast to generate $125,885,858 in revenue, with the lowest revenue forecast at $120,951,083 and the highest revenue forecast at $129,588,985.

What is MYNZ's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MYNZ) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 16.99%.

What is MYNZ's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: MYNZ) Mainz Biomed Nv's current Earnings Per Share (EPS) is -$5.41. On average, analysts forecast that MYNZ's EPS will be -$1.38 for 2026, with the lowest EPS forecast at -$1.32, and the highest EPS forecast at -$1.42. In 2027, MYNZ's EPS is forecast to hit -$1.50 (min: -$1.44, max: -$1.54).

What is MYNZ's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MYNZ) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.